Image

Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques in Iliotibial Band Syndrome

Recruiting
19 - 45 years of age
Both
Phase N/A

Powered by AI

Overview

Comparison of effects of autogenic inhibition and reciprocal inhibition muscle energy techniques on iliotibial band syndrome

Description

A single-blinded randomized control trial will be conducted over a period of one year in Foundation University Islamabad. Forty participants will be assigned to two groups: Group A (AI) and Group B (RI), with 20 participants each. The AI technique will involve a maximal isometric contraction of the target muscle followed by a stretch, while the RI technique will involve a maximal isometric contraction of the antagonist muscle followed by a similar stretching protocol. Both groups will perform the exercises 3 times per week for 2 weeks. Pain, Hip range of motion (ROM) and lower extremity function will be assessed using Numeric Pain Rating Scale (NPRS), goniometer and Lower Extremity Functional Scale (LEFS) respectively.

The outcomes will be measured in terms of improvements in pain score (NPRS), hip range of motion (ROM), and overall lower extremity function.

Eligibility

Inclusion Criteria

  • Both male and female participants
  • Age : 19-45years (8)
  • Lateral knee pain (>3 months)
  • Tenderness over lateral femoral condyle
  • Positive Flexibility Tests
  • Modified Ober's test (9)
  • Length assessment of Tensor Fasciae Latae and Iliotibial Band (10)
  • Positive Pain Provocation Tests
  • Renne's test
  • Noble's Compression test (11) *(individuals with 3 positive tests out of above mentioned 4 tests will be included)

Exclusion Criteria

  • Recent lower limb or pelvic girdle surgery within the past 3 months
  • Lower limb fractures or trauma within the past year.
  • Multiple lower limb surgeries (>2)
  • Presence of any structural or postural disorders (kyphosis or severe scoliosis)
  • Neurological disorders
  • Hip and knee Osteoarthritis
  • Rheumatoid Arthritis
  • Pregnancy

Study details

Iliotibial Band Syndrome

NCT06867159

Foundation University Islamabad

3 April 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.